INTRA CELLULAR THERAPIES INC's ticker is ITCI and the CUSIP is 46116X101. A total of 179 filers reported holding INTRA CELLULAR THERAPIES INC in Q3 2021. The put-call ratio across all filers is 0.27 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $20,577,000 | +160.8% | 380,000 | +79.5% | 4.67% | +739.7% |
| Q3 2021 | $7,890,000 | -56.2% | 211,670 | -52.0% | 0.56% | -61.8% |
| Q2 2021 | $17,997,000 | -13.9% | 440,889 | -28.4% | 1.46% | +106.7% |
| Q1 2021 | $20,901,000 | +49.7% | 615,989 | +40.3% | 0.70% | +14.5% |
| Q4 2020 | $13,960,000 | -7.9% | 438,989 | -25.7% | 0.62% | -43.9% |
| Q3 2020 | $15,165,000 | +26.6% | 590,989 | +26.7% | 1.10% | +15.1% |
| Q2 2020 | $11,975,000 | +212.9% | 466,502 | +87.3% | 0.95% | +230.9% |
| Q1 2020 | $3,827,000 | -90.6% | 249,002 | -79.1% | 0.29% | -95.7% |
| Q4 2019 | $40,870,000 | – | 1,191,200 | – | 6.62% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 700,000 | $42,833,000 | 8.57% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 308,819 | $18,897,000 | 7.82% |
| Vahanian & Associates Financial Planning Inc. | 45,533 | $2,786,000 | 6.44% |
| DCF Advisers, LLC | 238,500 | $14,594,000 | 6.39% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 50,956 | $20,930,000 | 4.72% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 1,531,923 | $93,738,000 | 2.86% |
| Nicholas Investment Partners, LP | 562,373 | $34,412,000 | 2.45% |
| Bellevue Group AG | 3,429,619 | $209,859,000 | 2.44% |
| WASATCH ADVISORS LP | 7,477,868 | $457,571,000 | 2.25% |
| Quantum Private Wealth, LLC | 73,772 | $4,514,000 | 1.95% |